Primary Lymphedema and Mutation CELSR1 (Cadherin EGF LAG Seven-pass G-type Receptor 1)
Clinical trial NCT04919655 · UNKNOWN
Trial details
- NCT number
- NCT04919655
- Sponsor
- University Hospital, Montpellier
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-02-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.